grand case study v7 final 030310
TRANSCRIPT
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
1/49
OBJECTIVES
I. General Objective
This study aims to present the case of a patient diagnosed with Kawasaki
Disease and highlight the nursing management associated with the medical care
provided to a patient with such a disease.
II. Specific Objectives
The following serve as a guide the accomplishment of the main objective:
1. Since Kawasaki Disease is a rare yet potentially debilitating disease mostly
seen in children, one of the goals of this study is to expand the knowledge
and appreciation of the disease by presenting its clinical manifestations,
complications, treatment, and prognoses;
2. Kawasaki Disease is a systemic vasculitic disease with possible affectations
of the heart, coronary arteries, skin, and lymph vessels, hence, this study
aims to promote the nursing interventions needed for the symptomatictreatment of the disease;
3. The incidence and treatment of Kawasaki Disease in the Philippines is not
well documented, therefore, another goal of this study is to potentially serve
as a significant reference for other researchers who wish to expand local
knowledge about the disease.
INTRODUCTION
1
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
2/49
I. Definition and History
Kawasaki Disease (KD) is an acute febrile vasculitic syndrome that affects
infants and young children. It is also known as Mucocutaneous Lymph Node
Syndrome (MLNS). KD is now the leading cause of acquired heart disease in
children in most developed countries. More than eighty-five percent (85%) of
cases are children below five years of age and the mortality rate is presently 0.1
to 2%. Mortality is based on complications, which include coronary arteritis,
coronary artery aneurysms and stenoses, and coronary thrombosis which may
lead to myocardial infarction, sudden death, or congestive heart failure. About
twenty-five percent (25%) of untreated KD patients develop coronary artery
aneurysms.
KD was first observed and diagnosed in 1961 by Dr. Tomisaku Kawasaki
at the Japan Red Cross Medical Center in Tokyo. Between 1961 to 1967, Dr.
Kawasaki reported fifty (50) infants and young children who presented with
several signs that included prolonged remittent fever, unilateral cervical
lymphadenitis, bilateral conjunctival injection, polymorphous erythematous rash,
erythema and edema of the hands and feet, inflammation of the lips and oralcavity, and subsequent desquamation of the fingers, toes, and periungual area.
He ruled out other possible diagnoses after negative laboratory results and was
convinced that he was treating a unique clinical syndrome. The first recorded
case that had cardiac involvement was in 1968, when Kawasaki and a colleague
reported a client manifesting with tachycardia, abnormal heart rhythm, and
cardiomegaly. Several years after, Kawasaki presented post-mortem evidence
of a number of patients diagnosed with KD who died due to coronary artery
complications.
KD is known to cause outbreaks in Japan, where the incidence of the
disease is about 150 to 175 cases per 100,000 children or more than 10,000 new
cases per year. In the United States, the incidence is about 15 per 100,000
children or less than 4,000 new cases per year.
2
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
3/49
II. Possible Risk Factors
The main cause or root of Kawasaki Disease is unknown. However,
possible risk factors and causes have been researched and studied to identify
the cause of the disease
1. Age
More than 90% of KD cases occur in children less than ten years of age.
Eighty-five percent (85%) of cases were diagnosed in patients less than five
years old and 50% in children younger than two years of age.
2. Gender
The ratio of male to female patients with KD is 1.5:1 internationally. It is
evidently more common in males than in females.
3. Race
Worldwide, Japan has the highest rate of incidence with approximately
10,000 new cases yearly. KD has been known to cause outbreaks in Japan
usually during the winter and spring seasons. In the United States, the
incidence is roughly 4,000 new cases yearly with rates intermediate among
African-Americans and those with Asian and South Pacific ancestry other
than Japan. In the Philippines, concrete data about the annual rate of KD isnot present.
The cause of KD is idiopathic although some studies suggest it to be
infectious. The bases for this assumption are the outbreaks reported in Japan
and the United States during the winter and spring seasons where the incidence
of KD doubles compared to the summer and fall seasons. Another reason for
this assumption is the fact that the acute stage of KD is self-limiting even without
IVIG medication.
The following possible pathologic agents have been suggested:
1. Parvovirus and Rotavirus infection
2. HIV
3
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
4/49
3. Rubella
4. Meningococcal septicemia
5. Klebsiella pneumoniae bacteremia
6. Coxiella burnettie
7. Human lymphotropic virus infection
III. Clinical Manifestations
Kawasaki Disease has diagnostic criteria to distinguish it from other
diseases with similar clinical manifestations.
1. Fever for at least 5 days with at least four (4) of the following features:
2. Bilateral conjuctival injection
3. Polymorphous exanthema or rashes
4. Changes in the lips and oral cavity (i.e. erythema, cracked lips, strawberry
tongue)
5. Changes in the peripheral extremities (i.e. edema in the hands and feet,
desquamation of fingers, toes, and periungual area)
6. Unilateral cervical lymphodenopathy (palpable; at least 1.5cm in diameter)
7. Exclusion of other diseases with similar presentations
The following signs and symptoms are present in the disease during its
stages:
Acute Stage (Days 1 to 11)
High fever
Irritability
Bilateral conjunctivitis
Rashes
Strawberry tongue and lip fissures (cracks)
Unilateral lymphadenitis
Mild hepatic dysfunction
4
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
5/49
Myocarditis, pericarditis, mitral valve regurgitation, and depressed
myocardial functioning can be recorded by electrocardiogram
Sub-acute Stage (Days 11 to 30)
Persistent irritability, anorexia, and conjunctival injection
Thrombocytosis
Decreased temperature
Arthritis or arthralgia
Desquamation of fingers and toes beginning at the periungual region
Development of coronary aneurysms
NOTE: This is the stage with the highest mortality
Convalescent Stage (Day 30 and above)
Inflammatory markers return to normal
Disappearance of signs and symptoms
Expansion of aneurysm leading to possible myocardial infarction
Smaller aneurysms resolve independently (60% of cases)
IV. Diagnostic Examinations and Medical Treatment
The laboratory findings in KD are non-specific, but indicative of illness:
Leukocytosis with neutrophilia (WBC in excess 15,000/mm3) with
predominance of immature or mature granulocytse
Elevated sedimentation rate (greater than 40mm/hour)
Anemia (Hgb is below 110g/L)
Thrombocytosis (Platelet count of more than 500,000/mm3)
Hypoalbuminemia and hyponatremia
Plasma lipid abnormalities
Sterile pyuria
Elevated serum transaminases
5
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
6/49
The medical treatment for Kawasaki Disease is intravenous
immunoglobulin (IVIG) with supportive medication of aspirin for anti-platelet
therapy:
DRUG DOSAGE FREQUENCY
IVIG 2g/kg infusion over 10 to 12
hours OR;
400mg/kg/day
* IVIG may be repeated if fever
persists or recurs together with at
least one classic sign of KD
Single dose
For 4 days
Aspirin 80-100mg/kg/day then;
3-5mg/kg/day
In 4 divided
doses until
14h day of
illness and
patient is
afebrile for at
least 3-4 days
Once daily for
6 to 8 weeks
IVIG is a purified preparation of gamma globulin. It is derived from large
collections of human plasma composed of several classes of antibodies. The
effect that IVIG has in the treatment of KD is not exactly known, but prognosis is
greatly improved after its administration no later than the tenth (10 th) day of
illness. IVIG aids in the treatment of systemic inflammation, which causes the
vasculitis in KD.
High-dose aspirin is used for the treatment of inflammation in KD. Low-
dose aspirin is used to inhibit platelet aggregation.
6
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
7/49
PATIENT PROFILE
I. Demographic Data
Name: Patient CDC
Age: 1.5 years old
7
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
8/49
Address: Blk15 Lot 10, Our Mahogany 1 Village, Pulo, Cabuyao,Laguna
Birthday: July 10, 2008
Birth Place: San Pablo City, Laguna
Religion: Roman Catholic
Sex: F
Nationality: Filipino
Mothers Name: Roselia Age: 33 y/o Occupation: Employee (Human Resources)
Fathers Name: Dante Age: 38y/o Occupation: Employee (Quality Control)
II. Admission Data and Notes
Hospital: Philippine Childrens Medical Center
Date and Time of Admission: January 26, 2010 at 8:05pm (Emergency Room)
January 27, 2010 (Ward 1C)
Admission Diagnosis: ATP t/c Kawasaki Disease
Chief Complaint: Persistent fever
Attending Physicians: Dr. H. Lim and Dr. O. Teormoso
Patient Weight: 11.5 kg
Vital Signs: Temperature 39.5C
Cardiac Rate 120 bpm
Respiration Rate 30 cpm
Blood Pressure 90/60 mmHg
Doctors Admission Notes:
System: awake, irritable
EENT: cry, cracked lips
Neck: (-) clap
Lungs: SLE (-) retractions
Heart: (-) murmur
Extremities: good pulses, (+) edema
Skin: (+) erythematous maculopapular rash in extremities
(+) papular lesions in upper extremities and abdomen
III. History of Present Illness
8
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
9/49
Patient CDC was admitted to the Emergency Room of the Philippine
Childrens Medical Center on January 26, 2010 at 8:05pm. He was later
transferred to Ward 1C (Non-Communicable Diseases) of PCMC on January 27.
The chief complaint of the patient was persistent fever as verbalized by the
mother.
Six (6) days prior to admission, patient had fever with minimal coughing.
Patient did not have rashes, diarrhea, or vomiting episodes. Patient was treated
with Paracetamol at 10ml per dose for fever. Patient still had good activity and
appetite.
Three (3) days prior to admission, patient still had fever associated with
erythema of the lips and eyes and rashes which erupted initially on the arms then
to the trunk. Mother was unable to document temperature due to unavailability of
thermometer.
Two (2) days prior to admission, patient still had fever and was seen at the
Laguna Health Center. Patient was given Paracetamol at 10ml per dose and
Chlorpheniramine three doses for allergy. The medications did not offer relief. In
the evening, the patient was given Cephalexin 125mg/5ml three times which also
offered no relief.
One (1) day prior to admission, patient was seen by a private doctor, whovisited patients home, due to persistent fever and papular rashes on the
extremities. CBC was done at ASJ Medical and Diagnostic Clinic and revealed
low platelet count. Patient was advised to be admitted to a hospital.
On the day of the admission, patient was seen by doctors in Jose Reyes
Memorial Medical Center. Patient was advised to go to PCMC.
IV. Past Medical History
Patient had no prior hospital confinements since birth. Patient did not
have any notable illnesses in the past.
V. Nutritional History
9
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
10/49
Patient CDC was breastfed for the first 2 weeks after birth. A milk formula
was given from 2 weeks after birth to present. Ratio of formula is 1:1 milk to
water given 6 ounces every 2 hours.
Patient started eating cereals, meat, fruits, fish, and vegetables on the
sixth (6th) month. Twenty-four (24) hours prior to confinement, patient ate bread
and milk for breakfast, and rice and soup for lunch and dinner.
Patient is given Celine for vitamins.
Patient has no known food allergies.
VI. Growth and Development
For gross motor development, patient was reported to be able to stand
and walk alone by the time he was 1 year old.
For adaptive development, patient is able to indicate needs through
minimal verbal cues and crying.
For personal/social development, patient is able to use a spoon. Parents
indicate that patient is able to let them know if she has urinated or defecated.
Patient was able to do these after turning 1 year old.
According to the physicians notes, patients growth and development are
at par with age with no delays in development.
VII. Family Health History
Fathers Side: (+) cardiovascular accident
(+) hypertension
Mothers Side: (+) hyperthyroidism
10
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
11/49
PHYSICAL ASSESSMENT
Name: Patient CDC
Age: 1 years old
Sex: Female
Department: Ward 1-C
Diagnosis: Kawasaki Disease.
Date and Time of Assessment: January 29, 2010 4:00 PM
I. General Survey
Received patient lying on bed, awake and responsive, not in any respiratory distress. With IVF of
0.9% NaCl 1000cc at right arm KVO. The patient measures 81cm in height and weighs 11.5kg. Patient appears to
be restless and irritable as evidenced by increased movement and uncontrollable crying. Patient does not appear
to be in respiratory distress.
II. Vital Signs
Techniques: Inspection, Palpation, Auscultation
Patient has temperature of 38.4C, axillary with cardiac rate of 121 beats per minute, regular respiratory rate
of 32 breaths per minute, and blood pressure of 90/60 mmHg.
11
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
12/49
PART TECHNIQUE NORMAL FINDINGS ACTUAL FINDINGS INTERPRETATION
Skin Inspectionand
Palpation
Color varies from light todeep brown
No edema
Moisture in skin folds andaxillae
Skin temperature isuniform within normalrange
Erythematous andmaculopapular rashesare present on the back,abdomen, chest, andextremities
Hands and feet arereddish, edematous,
shiny, and dry-looking
Skin is moist especially onareas with folds; presenceof desquamation onfingers, toes, and labialarea
Skin temperature isuniformly warm due toelevated bodytemperature
Presence oferythematous andmaculopapular rashesis one criteria indiagnosis of KawasakiDisease
Changes in theperipheral extremities
such as edema anddesquamation arecriteria for diagnosingKawasaki Disease
Changes in theperipheral extremitiessuch as edema anddesquamation arecriteria for diagnosingKawasaki Disease
Temperature of 38.4Cupon assessment;persistent fever for atleast 5 days is theearliest sign ofKawasaki Disease
Source: Textbook ofPediatric InfectiousDiseases, Fifth Edition byFeigin, Ralph D. andCherry, James D.
Head Inspectionand
Palpation
Configuration isnormocephalic
No lesions or tenderness
Head is normocephalic inshape
Absence of lesions and nosigns of tenderness
Normal
Normal
12
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
13/49
Anterior and posteriorfontanels are flat andclosed
Anterior and posteriorfontanels appear to be flatand closed
Normal
Hair Inspection Evenly distributed, thickhair, silky, resilient, noinfestation
Hair is thick, smooth,moist, and with no signs ofparasitic infestation
Normal
Eyes:Sclera
Cornea
Pupils
Eye Balls
Inspection
Inspection
Inspection
Inspection
Appears white
Transparent, shiny,smooth with cornealdetails visible
Black/brown in color;constricts whenilluminated and whenlooking at near objects;dilates when looking at farobjects
Symmetrically aligned
Eyeballs are symmetricalin size
Not protruding
Sclera is slightly reddish
Transparent, shiny,smooth; details apparent
Black in color; brisklyconstricts when illuminatedand dilates when notilluminated
Aligned
Eyeballs are symmetricalin shape and size
There is no protrusion
Bilateral non-purulentconjunctival injection
is one of the signs ofKawasaki Disease
Normal
Normal
Normal
Source: Textbook ofPediatric InfectiousDiseases, Fifth Edition byFeigin, Ralph D. andCherry, James D.
13
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
14/49
Palpebraland BulbarConjuctiva
Inspection Smooth, pink or red Bulbar conjunctiva areslightly reddish in color
Bilateral conjunctivalinjection is one of thecriteria in diagnosingKawasaki Disease
Source: Textbook ofPediatric InfectiousDiseases, Fifth Edition byFeigin, Ralph D. and
Cherry, James D.Ears Inspecton
andPalpation
Auricles fair in color
Symmetrical and alignedwith outer canthus of eyes
Auricles are flexible, firm,no tenderness
Absence of purulentdischarge in the externalcanal
Patient responds to sound
Auricles are fair in color,symmetrical in shape,flexible with no tenderness
There is no discharge fromthe ear canal
Responds to the voice ofmother and father
Normal
Normal
Normal
Nose Inspectionand
Palpation
Nares are patent
Septum on the midline
Mucosa is pinkish in color
Patent nares with septumon the midline
Mucosa is pinkish
Normal
Normal
Mouth Inspectionand
Palpation
Lips are moist and pinkishin color
Oral mucosa is pinkishwith no ulcerations
Lips are red in color, dry,and cracked
Oral mucosa is also deepred in color
Tongue is red and hasstrawberry-like texture
No ulcerations in oralmucosa
Changes in the mouthand oral mucosa are
some of the signs ofKawasaki Disease
Source: Textbook ofPediatric InfectiousDiseases, Fifth Edition byFeigin, Ralph D. andCherry, James D.
Neck Inspectionand
Neck is symmetrical
Thyroid glands are not
Neck is symmetrical
Presence of a swollen
Normal
Unilateral cervical
14
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
15/49
Palpation tender and enlarged
Neck muscles are equalin size
Trachea is positionedmidline upon palpation
lymph node on the leftside of the neck ; size ofthe lymph node isapproximately 1.5cm
Neck muscles are equal insize
Trachea is positionedmidline
lymphodenopathyappears in 50% to 75%of patients withKawasaki Disease
Normal
Normal
Source: Textbook of
Pediatric InfectiousDiseases, Fifth Edition byFeigin, Ralph D. andCherry, James D.
Chest Inspection,Palpation,Auscultation
Full and symmetric andnot bulging
Breathing is abdominaland posterior mobility andposture of thorax issymmetrical uponrespiration
Clear breath sounds
Chest is not bulging andappears symmetrical
Abdominal breathing ispresent (pediatric) withthoracic movementsymmetrical
No presence of harsh
breath sounds; patient wascrying and irritable duringassessment
Normal
Normal
Normal
Heart Auscultation S1 usually heard at allsites but louder at apicalarea
S2 usually heard at allsites but louder at base ofthe heart
S1 and S2 are heardaudibly on apical and baseareas of the heart
No murmur or gallops (S3and S4)
Normal
Breast Inspection Symmetrical in size andshape
Symmetrical in size andshape
Normal
15
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
16/49
Areola is round or ovaland color is light pink todark brown
Nipples are round, andequal in size
Areola is small and brownin color
Nipples are round andalmost in size
Normal
Normal
Finger andToe Nails
Inspectionand
Palpation
Vascular and pinkish incolor
Smooth texture
Intact epidermis
Capillary refill in 3-5seconds
Fingers and toes aredesquamated,
edematous, and reddishin color
Smooth texture
Intact epidermis
Capillary refill of 3 seconds
Changes inextremities such as
edema, desquamation,and redness are signsof Kawasaki Disease
Normal
Normal
Normal
Source: Textbook ofPediatric InfectiousDiseases, Fifth Edition byFeigin, Ralph D. andCherry, James D.
Abdomen Inspection,Auscultation,
Palpation
Unblemished skin,uniform in color
no evidence of liverenlargement
Audible bowel sounds
Presence oferythematous andpolymorphous rashes on
the trunk
no evidence of liverenlargement
Audible bowel sounds at12 per minute; abdomenproduces a growling sound
Presence ofpolymorphousexanthema or rashes
is one sign ofKawasaki Disease
Normal
Normal
Source: Textbook ofPediatric InfectiousDiseases, Fifth Edition byFeigin, Ralph D. andCherry, James D.
16
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
17/49
Muscles Inspection,Palpation
Equal size on both sidesof the body; nocontractures
Good muscle tone, firmwith smooth coordinatedmovements
Symmetrical in size onboth sides of the body
Good muscle tone with nosigns of uncoordinatedmotor movement
Normal
Normal
Source of Normal Figures: Fundamentals of Nursing: Concepts, Process, and Practice Seventh Edition by Kozier, Barbara and
Erb, Glenora
Maternal & Child Health Nursing: Care of the Childbearing & Childrearing Family Fifth Edition byPillitteri, Adele
17
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
18/49
ANATOMY
Kawasaki Disease, otherwise known as Mucocutaneous Lymph Node Syndrome,
is an acute, self-limiting, and febrile systemic vasculitis that may cause cardiac
complications. The most common sequel of KD is coronary thrombosis (stagnant blood
clot) that possibly leads to the development of a coronary aneurysm. Having these
definitions and descriptions of the disease in mind, the following body systems and
structures will be discussed briefly to illustrate the physiological effects of KD.
I. Heart
The heart functions as the primary organ for blood circulation in the
human body. It is responsible for delivering un-oxygenated blood from the
venous system to the lungs and oxygenated blood from the lungs to the arterial
circulation. Additionally, the heart propels blood throughout the systemic
(arterial) circulation to bring nutrients, vital enzymes, hormones, and drugs to the
tissues and organs of the body. The image of the heart, its parts and functions,
are illustrated in Figure 1 and Table 1 respectively.
FIGURE 1: THE HEART AND ITS STRUCTURES
18
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
19/49
TABLE 1: THE PARTS OF THE HEART AND CORRESPONDING FUNCTION
STRUCTURAL PARTS FUNCTION
Superior Vena Cava (SVC) One of the two main veins that drains un-
oxygenated blood to the right atrium
Blood from the head and upper body
drain into the SVC
Inferior Vena Cava (IVC) The second main vein that drains un-
oxygenated blood to the right atrium
Blood from the legs and lower torso drain
into the IVC
Aorta The largest single blood vessel in the
body
Passageway for oxygen-rich blood from
the left ventricle into the systemic
circulation
Pulmonary Artery The only artery in the body that carries
deoxygenated blood
Passageway of deoxygenated blood from
the right ventricle to the lungs
Pulmonary Vein The only vein in the body that carries
oxygenated blood
Carries oxygenated blood from the lungs
to the left atrium
Right Atrium A chamber of the heart that receives
deoxygenated blood from the SVC and
IVC
Pumps blood into the right ventricle via
the tricuspid valveRight Ventricle Receives deoxygenated blood from the
right atrium via the tricuspid valve
The tricuspid valve closes after the right
ventricle fills up with blood and the
19
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
20/49
pulmonary valve opens to allow
deoxygenated blood to flow into the
pulmonary artery
Left Atrium Receives oxygenated blood from the
pulmonary vein
Blood from this chamber empties into the
left ventricle via the mitral valve
Left Ventricle Arguably the largest chamber of the
heart, receives oxygenated blood from
the left atrium via the mitral valve
The mitral valve is open as the left
ventricle fills up with blood from the leftatrium and it closes once the left ventricle
is filled. The aortic valve opens as the
left ventricle contracts, sending
oxygenated blood into the aorta and into
the systemic circulation
Atrioventricular Valves The tricuspid and mitral valves ensure
one-way blood flow within the chambers
of the heart
The tricuspid valve is the gateway
between the right atrium and the right
ventricle
The mitral valve is the gateway between
the left atrium and the left ventricle
Semilunar Valves The pulmonary and aortic valves ensure
one-way blood flow into the pulmonary
artery and aorta respectively
20
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
21/49
II. Coronary Arteries
The coronary arteries constitute the coronary circulation that supplies
oxygenated blood to the heart itself. These arteries receive their blood supply
from openings in the aorta called the coronary ostia.
A major complication of Kawasaki Disease is the development of coronary
aneurysms and coronary thrombosis, thus making the discussion of the coronary
arteries relevant. Ruptured coronary aneurysms lead to massive bleeding and
ischemia, eventually resulting to myocardial infarction.
The main branches of the coronary arteries and the areas of the heart
they supply are detailed below (Figure 2 and Table 2).
Figure 2: The Coronary Circulation
21
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
22/49
Table 2: The Branches of the Coronary Arteries
BRANCHES OF THE
CORONARY ARTERIES
PARTS SUPPLIED
Left Coronary Artery Divides into two branches: the left anterior
descending artery and the circumflex artery
Left Anterior Descending Artery Delivers blood to sections of the left and
right ventricles and majority of the
interventricular septum
Circumflex Artery Supplies blood to left atrium and the lateral
wall of the left ventricle
Right Coronary Artery Three major branches: conus, right marginal
branch, and posterior descending branch
The conus supplies blood to the right upper
ventricle, the right marginal branch supplies
the right ventricle up to the apex, and the
posterior descending branch supplies
minority sections of the ventricles
22
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
23/49
III. Vascular System
The vascular system is made up of the arteries and veins of the body.
Arteries branch into smaller arterioles, which branch further into capillaries.
Capillaries serve as the site where nutrient exchange between the blood and
tissues occur. Blood from the capillaries then enter venules that eventually join
together to form larger veins. The arteries serve as the channels for oxygenated
blood (systemic circulation) and the veins serve as the channels for
deoxygenated blood.
As a systemic vasculitic disease, Kawasaki Disease causes inflammation
of the blood vessels resulting to edema, increased permeability of the vessels,
and coronary aneurysms (weakening of the blood vessel walls). Figure 3 and
Table 3 briefly discuss the structure and functions of the vascular components.
Figure 3: The Vascular System
23
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
24/49
Table 3: Comparison of Arteries and Veins
ARTERIES PARTS VEINS
Thinner than the tunica
media
Tunica Adventitia (outer
layer)
Thickest layer
Thicker than the tunicaadventitia allowing
vasoconstriction and
vasodilation
Tunica Media (middlelayer)
Thinner in veins
Same Tunica Intima (inner layer) Same
Narrower Lumen Wider to accommodate
valves
Absent Presence of Valves Present; to ensure the one-
way flow of blood back to
the heart
Fastest in arteries and gets
slower when entering the
arterioles and capillaries
Blood Flow Slow in the venules, but
increases speed as it
passes through the veins
(valve-related)
Aorta (largest), pulmonary
artery, carotid arteries,
subclavian artery,
brachiocephalic, abdominal
aorta, common iliac, brachial
Major Blood Vessels Superior and inferior vena
cavae, jugular veins,
subclavian veins, hepatic,
iliac, femoral, hepatic portal
24
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
25/49
Figure 4: Arteries of the Body
Figure 5: Veins of the Body
25
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
26/49
IV. Lymph Nodes
The lymph nodes are some of the major structures of the lymphatic
system, which works closely with the circulatory system to bring interstitial fluid
back into the blood circulation. Functionally, however, lymph nodes are part of
the hematologic and immune systems because large numbers of lymphocytes,
monocytes, and macrophages reside in these nodes. These cells are mobilized
and join the circulating blood during infection or inflammation.
In Kawasaki Disease, there is unilateral lymphodenopathy, meaning that
the lymph nodes enlarge due to inflammation. What causes this inflammation is
still unknown, but since unilateral lymphodenopathy is one criterion in diagnosing
KD, it is worth to include it in the anatomy section of this study.
Figure 6: Parts of a Lymph Node
26
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
27/49
27
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
28/49
PATHOPHYSIOLOGY
Sources:
1. Textbook of Pediatric Infectious Diseases Fifth Edition by Feigin, Ralph D. andCherry, James D.
2. Kawasaki Disease by Scheinfeld, Noah S. and Jones, Elena L.
http://emedicine.medscape.com/article/965367-overview
28
Diagnostic indicators
Complications if untreatedwithout IVIG 10 days after onset
of fever
Signs and symptoms inpatient
Diagnosis of KawasakiDisease based on
diagnostic criteria ofdisease;
Age is the only probablepredisposing factor in
patient
(+) fever
(+) maculopapularerythematous rashes onhands, feet, trunk, and
abdomen;(+) edema of hands and
feet;(+) desquamation of
fingers, toes, andperiungual area
(+) palpable unilateral
cervicallymphadenopathy at
1.5cm
(+) bilateral nonpurulentconjunctivitis
(+) cracked lips;(+) strawberry tongue;
Remittent fever for 6days PTA;
T = 39.5C on DOA
Platelet level of 411 x103 g/L based on CBC;
ESR of 112 mm/hrbased on CBC
WBC count of 19.7 g/L
based on CBC;Segmenter count of 0.85
hpf based on CBC
Coronary aneurysm;Coronary thrombosis;
Coronary stenosis;Coronary arteritis
Myocardial infarction;Congestive heart
failure;Death
http://emedicine.medscape.com/article/965367-overviewhttp://emedicine.medscape.com/article/965367-overview -
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
29/49
Discussion:
The etiology of Kawasaki Disease is still unknown. Studies have failed to identify
a pathologic agent that causes the disease. Most clinicians believe the disease has an
infectious nature due to the presence of seasonal outbreaks in Japan. The only non-
modifiable risk factors with considerable theoretical basis are age and race. Most casesinvolve children below 10 years of age and Japanese children appear to be at a higher
risk of acquiring the disease. However, the incidence of KD in Asians and other Pacific
Islanders is higher compared to Westerners of Caucasian or African descent.
The patient manifested 5 out of the 6 signs in the criteria for diagnosing
Kawasaki Disease. The patient had remittent fever for 6 days, had rashes that started
in the arms and spread to the trunk, oral cavity changes manifested by cracked lips,
strawberry tongue, and reddened oral mucosa, bilateral conjunctivitis, and a palpable
lymph node on the lefts side of the neck. These clinical manifestations were supported
by the hematological test and vital signs of the patient: a temperature of 39.5C,elevated platelet (thrombocytosis) and ESR (inflammatory response) levels, and a left
shift (increased production of mature leukocytes) in the patients WBC differential
results. The hematological results further provide evidence of the multi-system
affectations of the disease indicating signs of inflammation (vasculitis in KD), formation
of blood clots, and abnormal increase in WBCs (manifested in lymphadenopathy.
Twenty-five percent (25%) of cases result to coronary artery complications
without IVIG therapy and 3% of cases lead to the same complications even with IVIG
therapy. The coronary artery complications include formation of blood clots, arterial
stenosis, arteritis, and aneurysms. If these complications are not detected, the worst-case prognoses are myocardial infarction, congestive heart failure, and death. KD has a
0.1 to 2% mortality rate globally.
29
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
30/49
DIAGNOSTIC EXAMINATIONS
Hematology Section - PCMC
Name: Patient CDC
Date received: January 26, 2010 - 9:34 pm
Date released: January 26, 2010 - 10:34 pm
PARAMETERS RESULTS NORMAL
VALUES
FINDINGS ANALYSIS
Hemoglobin
(HGB)
107.6 116-140g/L Below normal Indicative of
anemia, which
is a diagnostic
predictor ofKawasaki
Disease
Hematocrit
(HCT)
0.34 0.35-0.41g/L Slightly below
normal
Lysis of RBC
is possibly
due to
vasculitic
affects of
disease
RBC 4.36 3.6-50g/L Normal There is noabnormal
finding
WBC 19.7 5-10g/L Remarkably
above normal
Indicative of
leukocytosis
secondary to
infection or
inflammation
Differential Count
30
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
31/49
PARAMETERS RESULTS NORMAL
VALUES
FINDINGS ANALYSIS
Eosinophils 0.01 0.02-0.07hpf Slightly below
normal
Possibly due to
allergic
reactions
Segmenter 0.85 0.55-0.65 hpf Remarkably
above normal
Overproduction
of mature
leukocytes
indicative of
increased
autoimmune
response
Lymphocytes 0.14 0.25-0.35 hpf Remarkably
below normal
Indicative of
immunosupp-
ression
Platelet Count 411 150-350 x
103 /L hpf
Remarkably
above normal
Indicative of
thrombocytosis,
which appears
on the 2nd week
of Kawasaki
Disease
ESR 112 0 -20 mm/hr Remarkably
above normal
Indicative of
inflammatory
response
ASJ Medical and Diagnostic Clinic
Hematology
31
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
32/49
Date of Release: January 25, 2010
PARAMETERS RESULTS NORMAL
VALUES
FINDINGS ANALYSIS
Hemoglobin
(HGB)
106 116-140g/L Below normal Indicative of
anemia
Hematocrit
(HCT)
0.32 0.35-0.41g/L Slightly below
normal
Indicative of
low RBC
count due to
hematologic
factors
ErythrocyteCount
3.7 3.6-50g/L Normal Within normal
range
LeukocyteCount
5.75 5-10g/L Normal Within normal
range
Platelet Count 98,000 150,000
300,000
Below normal Indicative of
thrombocyto-
penia
Differential Count
PARAMETERS RESULTS NORMAL
VALUES
FINDINGS ANALYSIS
Eosinophils 0.03 0.02-0.07hpf Normal Within normal
range
Segmenter 0.55 0.55-0.65 hpf Normal Within normal
range
Lymphocytes 0.40 0.25-0.35 hpf Slightly above
normal
Indicative of
autoimmune
response
Monocytes 0.02 0.02-0.05 Normal Within normal
32
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
33/49
range
33
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
34/49
DRUG STUDY
DRUG DOSAGE MECHANISM OF
ACTION
INDICATION CONTRAINDICATION ADVERSE
EFFECT
NURSING
RESPONSIBILITIES
Drug Name:
IMMUNOGLOB-ULIN IV
Drug Class:
Passive immune-globulin
2.5g/50ml 10 vials:
Test Dose I:0.01x11.5kgx60= 7cc for 30mins
Test Dose II:0.02x11.5kgx60=14cc
Test Dose III:0.03x11.5kgx60=21cc
Test Dose IV:0.04x11.5kgx60=28cc
Translateremaining 390cc to24cc/hr for 16hrs
Improves immunityby binding to and
neutralizing
pathogens, thereby
increasing
antibodies against
bacterial, viral,
parasitic, and
mycoplasmic
antigens. Acts
through
antimicrobial and
antitoxin
neutralization.
KawasakiSyndrome
Prophylaxis after
exposure to
Hepatitis A
B-cell chronic
lymphocytic
leukemia
Pediatric HIV
infection
Patients withanaphylactic reaction to
IGIV
Tenderness,muscle stiffness at
injection site,
nausea, vomiting,
chills, fever,
headache.
- Do not administer topatients with history of
allergy to gammaglobuli
- Instruct patient to repor
symptoms occurring
during or after therapy.
- Use with caution in
pregnant women-
Pregnancy C; safety not
established
- Have epinephrine 1:10
immediately available at
time of injection in case
anaphylactic reaction
- Do not mix immune
globulin with any other
medications
- Monitor patients VS
continuously
- Provide or teach patien
to provide safety
measures.
34
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
35/49
- Advise patient to avoid
live-virus vaccines for 3
months after therapy; dr
may delay or inhibit body
response to vaccine.
- Provide patient with
written record of injection
and dates for follow-up
injections as needed.
DRUG DOSAGE MECHANISM OF
ACTION
INDICATION CONTRAINDICATION ADVERSE
EFFECT
NURSING
RESPONSIBILITIES
Drug Name:
ASPIRIN
Classification:
Antipyretic,analgesic, NSAID
300mg/tab; 1 tab
q6 PO
It acts in the
thermoregulatory
center of the
hypothalamus to
block effects of
pyrogen
Also has anti-
inflammatory, anti-
platelet, and
analgesic
properties
Mild to moderate
pain
Fever
Inflammatoryconditions-
rheumatic fever,
rheumatoid
arthritis,
osteoarthritis
Allergy to NSAID or
salicylates
Hemophilia;
hemorrhagic states;
impaired renal function;chickenpox; pregnancy
Acute aspirin
toxicity: tachypnea,
hemorrhage,
excitement,
confusion
GI: nausea,
dyspepsia,
heartburn,
epigastric
discomfort,
anorexia
- Give drug with food or
after meals if GI upset
occurs.
- Use the drug only as
suggested; avoidoverdose.
35
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
36/49
NURSING CARE PLAN
The following nursing problems were based on the data gathered for this study:
I. Actual Nursing Problems
1. Elevated body temperature related to systemic inflammation of blood
vessels secondary to present disease
2. Impaired skin integrity related to accumulation of fluid in the interstitial
spaces of hands and feet secondary to present disease
3. Impaired oral mucous membrane related to inflammation of oral mucosa
secondary to present disease
II. Potential Nursing Problems
1. Risk for decreased cardiac output related to possible coronary artery
complications secondary to present disease
36
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
37/49
ACTUAL NURSING PROBLEMS
1. Elevated body temperature related to systemic inflammation of blood vessels secondary to present disease
ASSESSMENT DIAGNOSIS INFERENCE PLANNING INTERVENTION RATIONALE EVALUATIONSubjective:NONE
Objective:
Temp 38.4C;
Warm to touch;
Irritable andrestless;
Uncontrolledcrying
Elevated bodytemperaturerelated tosystemic
inflammationof bloodvesselssecondary topresentdisease
Presentdisease
Systemicinflammationof bloodvessels
Release ofpyrogens
Elevated bodytemperature
Short-term:
After 2 hoursof nursing
intervention,the patientstemperaturewill normalizeat 37.5C.
Independent:
Checktemperature and
other vital signsprior tointerventions;
Administer tepidsponge bath tolowertemperature;
Provide a changeof clothes andsheets to promote
increasedcomfort;
Regularly checkdiapers if soiled;
Assessmentof all vital
signs isintegral toplanning andintervention;
TSB is anindependentnursingfunction thatlowers coretemperature;
Increasingpatientcomfort can
ease irritabilityandrestlessnessassociatedwith fever;
Soiled diaperscauseadditionaldiscomfort;
After 2 hours ofnursingintervention, thepatients body
temperaturewas lowered to37.8C; tocontinueinterventionsuntil bodytemperaturenormalizes
37
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
38/49
Follow feedingschedule toprovide nutritionalsupport;
Watch out forsigns ofdehydration
Dependent:Administer aspirinas ordered;
Check the flowrate of IVIG andwatch out forsigns of adverseeffects
Infants requiresufficientnutritionespeciallyduring timesof illness andimmuno-suppression;
Dehydration iscommon ininfants withpersistentfever
Aspirin servesas anantipyretic,anti-inflammatoryand anti-platelet drug
in KawasakiDiseaseProperregulation ofIVIG infusionis important toprevent sideeffects
2. Impaired skin integrity related to accumulation of fluid in the interstitial spaces of hands and feet secondary to
present disease
38
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
39/49
ASSESSMENT DIAGNOSIS INFERENCE PLANNING INTERVENTION RATIONALE EVALUATIONSubjective:NONE
Objective:
+ 1 edema ofhands and feet;
Skin appears dryand shiny;
With erythema ofhands and feet;
desquamation offingers and toes
Impaired skinintegrityrelated toaccumulationof fluids ininterstitialspaces of
hands andfeetsecondary topresentdisease
Presentdisease
Systemicinflammation
of blood
vessels
Increase inhistaminerelease
Greaterpermeability
of bloodvessels
Vascular fluid
moving tointerstitialspaces ofhands and
feet
Impaired skin
Short-term:After 6 hoursof nursingintervention,skin integrityimproved asevidenced by
controlleddryness of theskin
Long-term:
After 3 to 4days ofnursingintervention,skin integrityproblemsrelated toedema willresolve as
evidenced byedema scoreof 0 from +1
Independent:
Assess the handsand feet for extentof dryness andedema;
Assess mobility offingers, toes,hands, feet,wrists, andankles;
Apply RICEtechnique inmanagement ofedema;
Apply lotion to dry
Assessmentof sites ofedema willdictateprovision
interventions;
Mobility is asign ofsufficientblood flow tosites;
R- rest;I ice todecreaseinflammation;C compressionto promote
venous returnand lymphaticdrainage offluid;E elevateabove theheart forvenous return;
Lotion can
After 6 hours ofnursingintervention,skin integrityimproved withcontrolleddryness of the
skin ; skin ismore moist onsites of edema
39
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
40/49
integrity areas of skin for moisture andlubrication;
Do not peel offdesquamatedskin;
Watch out forwounds and signsof infection andloss of function
Dependent:Administer aspirinas prescribed;
Check flow ofIVIG asprescribed
hasten furtherdrying of theskin due toedema;
Desquamatedskin will peeloff naturally;you can cutloose skin atthe ends;
Edema anddryness makeskinsusceptible towounds
Aspirin hasanti-inflammatoryproperties;
IVIG therapyaids in abatinginflammation,thus reducingedema
3. Impaired oral mucous membrane related to inflamed oral mucosa secondary to present disease
ASSESSMENT DIAGNOSIS INFERENCE PLANNING INTERVENTION RATIONALE EVALUATIONSubjective: Impaired oral Present Short-term: Independent: After 3 hours of
40
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
41/49
NONE
Objective:
With fissured,cracked lips;
Witherythematouslips;
red and inflamedoral mucosa;
Strawberry-liketongue withpapules;
Irritable whenbeing givenfeedings
mucousmembranerelated toinflamed oralmucosasecondary topresentdisease
disease
Inflamed oralmucosa
Poor bloodperfusion tooral mucousmembrane
Impaired oralmucous
membrane(evidenced bycracked lips)
After 3 hoursof nursingintervention,fissures andcracks in thelips will becontrolled andlessened
Long-term:
After 3 to 4days ofnursingintervention,fissures andcracks willresolve asevidenced bymoist lips withthe absenceof cracks and
fissures
Assess the extent,characteristic, andseverity of thefissures andcracks on the lips;
Assess if there isdifficulty inswallowing oralterations infeeding;
Provide oralrinses using tapwater or salinedrops to moistenmucosa;
Provide regularoral care hygieneby giving oralrinses;Encouragesufficient fluid
Assessmentof the fissuresand cracks onthe lips willaffectinterventionsto be given;
Fissured andcracked lipscan causedifficulty infeeding,especially ininfants;
Moisteningdried mucosawill preventworsening ofcracks andprevent new
ones fromdeveloping
Non-alcoholicrinses willpreventinfectionDehydrationcan contribute
nursinginterventions,fissured andcracked lipswere managedas evidenced bycontrolleddryness of thelips
41
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
42/49
intake asprescribed andtolerated;
Instruct mother toavoid giving acidicfluids;
Instruct mother tocontinue feedingpractices asprescribed byphysician
Watch out forsigns of infection
Independent:
Administer aspirinas prescribed
to mucosaldryness andworsencracked lips;
Juices andother acidicbeveragescause pain inopen oralmucosa;
Feedingpracticesshould beencouraged inspite ofcondition
Further dryingof mucosa canlead to ulcersand result to
infection
Aspirin hasanalgesic andanti-inflammatoryproperties
42
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
43/49
Potential Nursing Problems
1. Risk for decreased cardiac output related to possible coronary artery complications secondary to present disease
ASSESSMENT DIAGNOSIS INFERENCE PLANNING INTERVENTION RATIONALE EVALUATIONSubjective:None
Objective:
Risk fordecreasedcardiac outputrelated to
Presentdisease
Short-term:
After 2 hoursof nursing
Independent:
Assess thepatients cardiac
It is importantto retrieve
After 2 hours ofnursingintervention, theparents were
43
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
44/49
None possiblecoronaryarterycomplicationssecondary topresentdisease
Increasedplatelet
production
Formation ofblood clots inblood vessels,
particularlythe coronary
arteries
Blood clotscan causeblockage,
aneurysms,and stenosisof coronary
arteries
All these
complicationscan causedecreased
cardiac output
intervention,the parentswill be able toverbalizeunderstandingof the cardiaccomplicationsof presentdisease
vital signs prior todischarge;
Discuss withparents the natureof KawasakiDisease and thepossiblecomplicationseven with IVIGtherapy;
Provide parentswith aninformation sheetregarding post-drug therapy carefor patients withKawasakiDisease;
Instruct parents topromote adequaterest and sleep 2-3days afterdischarge fromhospital;
Instruct parents togradually
baseline VSprior todischarge forreference;
Clienteducation isimportant incomprehen-sion of illness
A quickreferenceguide canincreaseunderstan-ding ofdisease;
Patients fullrecovery hasto be ensured;
Gradualreintroduction
able tounderstand therisk for cardiaccomplicationsas evidenced byverbalization oftheircomprehensionof healthteachings
44
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
45/49
reintroducepatient toactivities;
Educate patientson signs ofcardiac problems;
Promote abalanced diet withlow sodiumcontent;
Advise parentsregarding followup check-up anddiagnosticprocedures
to activitieswill helppatient adaptefficiently afterillness;
Signs ofcardiaccomplicationsinvolveshortness ofbreath, activityintolerance,difficulty inbreathing,dizziness,lethargy, andchest pain;
Propernutrition willensure growthand
development;
Follow upcheck-ups willhelpdeterminedevelopmentof any cardiacabnormalitiesor coronary
45
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
46/49
arteryaffectations
46
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
47/49
DISCHARGE PLANNING
Medication
Discuss all take home medications to patient's mother
Aspirin: advise parents to give drug after meals to prevent gastric irritation
Aspirin: advise parents regarding side effects of drug such as nausea,vomiting, abdominal pain, and headache
Aspirin: advise parents to adhere to frequency, dosage, and timeliness ofdrug administration
IVIG: educate parents regarding immunosuppressive effects of drug
IVIG: educate parents regarding side effects of drug such as chills, fever,
and headache
Advise parents to report any changes in the patient related to drugs beingtaken
Exercise
Advise parents of adequate rest and sleep for up to 2 to 3 days after discharge topromote recovery
Advise parents to gradually increase activities; start with light activities until
tolerated before engaging in more strenuous activities
Encourage parents to have patient engage in normal activities of daily living suchas self-feeding, dressing, and walking
Constantly monitor activity and exercise pattern to detect any abnormalities suchas cardiac affectations/sequelae of Kawasaki Disease
Treatment
Explain to the patients that drug therapy should continue as prescribed byphysician
Educate parents regarding potential sequelae of Kawasaki Disease such ascoronary artery and cardiac problems
Health Teachings
Advise parents to promote proper hygiene to decrease possibility of infection
47
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
48/49
Encourage parents to promote a safe, comfortable, and clean environmentconducive to recovery of patient
Provide nutritional teaching to parents to foster improved nutritional and fluidintake as well as promote balanced diet
During recovery, patient should not be brought to crowded places to preventcommunity-acquired infections
Advise mother to complete all immunizations and booster shots for patient oncecleared by physician
Promote regular hand washing especially during food preparation to avoidcontamination of food
Out Patient
Remind the family on their follow up check up with their physician
Encourage to take routine cardiac diagnostic examinations (i.e. MRI, CTscans of
the heart, and 2D echocardiography) to determine presence of cardiac
affectations/complications of disease
Diet
Encourage to have the three basic food groups in the diet while controlling salt
intake
Encourage to increase fluid intake
Encourage to prepare foods that are rich in vitamins and minerals to improve
immune system
Continue milk feeding and solid food combination and introduce new viands to
improve appetite and expand food variety
Spiritual
Guided by the family, help the patient to establish deep personal relationship withGod in everyday of her waking moment
With guidance from parents and family, help the patient find happiness in her
present situation
Aid patient in holistic development of self to promote overall wellness
48
-
8/7/2019 GRAND CASE STUDY V7 FINAL 030310
49/49
REFERENCES
Books
Feigin, Ralph D. et al., Textbook of Pediatric Infectious Diseases Volume 1. Fifth
Edition. Elsevier Inc., Philadelphia, USA: 2004.
Huether, Sue E. and McCance, Kathryn L.,Understanding Pathophysiology 3 rd Edition.
Mosby Inc., Singapore: 2004.
Kozier, Barbara et al., Fundamentals of Nursing: Concepts, Process, and Practice
Seventh Edition. Prentice Hall, New Jersey, USA: 2004.
Pillitteri, Adele, Maternal & Child Health Nursing: Care of the Childbrearing &
Childrearing Family Volume 2 Fifth Edition. Lippincott Williams & Wilkins, USA:
2007.
Internet
Gordon, John B. et al. When Children with Kawasaki Disease Grow Up: Myocardial and
Vascular Complications in Adulthood., Journal of the American College of
Cardiology as seen on http://www.medscape.com/viewarticle/712188
Moran, Adrian M. et al. Abnormal Myocardial Mechanics in Kawasaki Disease: Rapid
Response to Gamma-Globulin., American Heart Journal 02/01/2000 as seen on
http://www.medscape.com/viewarticle/409087
Scheinfeld, Noah S. and Jones, Elena L. Kawasaki Disease., 10/20/2009 as seen on
http://emedicine.medscape.com/article/965367-overview